Glucagon in the scintigraphic diagnosis of small-bowel hemorrhage by Tc-99m-labeled red blood cells

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Twelve patients undergoing scintigraphy with Tc-99m-labeled red blood cells (RBC) exhibited abnormal small-bowel activity and were given glucagon to assess its role in detecting bleeding from the small bowel. Six demonstrated focal accumulation of activity which was not identified prior to glucagon. Endoscopy, barium studies, angiography, and colonoscopy located the small-bowel bleeding site in 4 patients; in the other 2, studies of the colon failed to show the bleeding site and the origin was presumed to be the small bowel. The authors suggest that intravenous glucagon can be beneficial as an adjuvant to Tc-99m-RBC when diagnosing bleeding from the small bowel.

Original languageEnglish (US)
Pages (from-to)239-242
Number of pages4
JournalRadiology
Volume151
Issue number1
DOIs
StatePublished - Jan 1 1984
Externally publishedYes

Fingerprint Dive into the research topics of 'Glucagon in the scintigraphic diagnosis of small-bowel hemorrhage by Tc-99m-labeled red blood cells'. Together they form a unique fingerprint.

Cite this